The World Health Organization (WHO) recommends iron-folic acid (IFA) supplementation during pregnancy to improve maternal and infant health outcomes. Multiple micronutrient (MMN) supplementation in pregnancy has been implemented in select countries and emerging evidence suggests that MMN supplementation in pregnancy may provide additional benefits compared to IFA alone. In 2015, WHO, the United Nations Children 0 s Fund (UNICEF), and the Micronutrient Initiative held a "Technical Consultation on MMN supplements in pregnancy: implementation considerations for successful incorporation into existing programmemes," which included a call for indicators needed for monitoring, evaluation, and surveillance of MMN supplementation programmes. Currently, global surveillance and monitoring data show that overall IFA supplementation programmes suffer from low coverage and intake adherence, despite inclusion in national policies. Common barriers that limit the effectiveness of IFA-which also apply to MMN programmes-include weak supply chains, low access to antenatal care services, low-quality behaviour change interventions to support and motivate women, and weak or non-existent monitoring systems used for programme improvement. The causes of these barriers in a given country need careful review to resolve them. As countries heighten their focus on supplementation during pregnancy, or if they decide to initiate or transition into MMN supplementation, a priority is to identify key monitoring indicators to address these issues and support effective programmes. National and global monitoring and surveillance data on IFA supplementation during pregnancy are primarily derived from cross-sectional surveys and, on a more routine basis, through health and logistics management information systems. Indicators for IFA supplementation exist; however, the new indicators for MMN supplementation need to be incorporated.
| INTRODUCTION
Iron deficiency remains the most common micronutrient deficiency worldwide, particularly affecting children and women of reproductive age, including pregnant women (www.who.int/nutrition/topics/ida/ en/; Kassebaum et al., 2014; Stevens et al., 2013) . The World Health Organization (WHO) currently recommends a daily dose of 30-60 mg elemental iron (60 mg preferred in setting where anaemia prevalence >40%) and 0.4 mg folic acid taken as early as possible in pregnancy to improve maternal and infant health outcomes (World Health Organization, 2012; World Health Organization, 2016) .
Continued supplementation beyond pregnancy is also recommended if iron deficiency prevalence in the country is high, or if the pregnant woman is anaemic (Stoltzfus & Dreyfuss, 1989) . Iron and folic acid (IFA) supplementation during pregnancy reduces anaemia and iron deficiency at term, as well as the risk of low birth weight (Peña-Rosas, De-Regil, Dowswell, & Viteri, 2012) . Other micronutrient deficiencies, beyond iron and folate deficiency-such as vitamin A, vitamin D, vitamin B 12 and zinc-are also widely prevalent among women of reproductive age, particularly pregnant and lactating women in developing countries (Bhutta et al., 2013; Dalmiya, Darnton-Hill, Schultink, & Shrimpton, 2009; Jiang, Christian, Khatry, Wu, & West, 2005; World Health Organization, 1992) . Poor maternal nutrition is frequently caused by poor access to nutrient-adequate foods, cultural practices that discourage women from gaining weight, long hours of physical labour, and recurrent infections (Christian, 2010) . In 1999, Efficacy and effectiveness trials have confirmed that MMN supplementation during pregnancy can improve outcomes beyond anaemia, including deficiencies of other vitamins and minerals, low birth weight, small for gestational age (Dalmiya et al., 2009; Fall, Fisher, Osmond, & Margetts, 2009) , and preterm birth (West et al., 2014 [0.83, 0.97]) , and a reduced rate of stillbirth (RR 0.91, 95% CI [0.85, 0.98] ; Haider & Bhutta, 2015) . There were no significant differences for other maternal and pregnancy outcomes such as preterm births, maternal anaemia in the third trimester, miscarriage, maternal mortality, perinatal mortality, neonatal mortality, or risk of delivery via a caesarean section (Haider & Bhutta, 2015) . Though the evidences were with insufficient data on neurodevelopmental and long-term follow-up of maternal and offspring outcomes, these findings still support the potential replacement of IFA supplements in pregnancy with MMN supplements in populations at risk (Bhutta et al., 2013) .
According to the WHO/Centers for Disease Control and Prevention (CDC) logic model for vitamin and mineral intervention in public health programmes (De-Regil, Peña-Rosas, Flores-Ayala, & Jefferds, 2014), most micronutrient programmes are expected to follow particular intervention processes. These processes require inputs to support relevant policies, adequate production and supply, delivery of the programme, quality control, and behaviour change communication and intervention strategies in order to achieve expected outputs and outcomes ( Figure 1 ). All programmes also require effective programme management and monitoring. However, global surveillance data show that IFA supplementation programmes often suffer from low coverage and intake adherence of supplements, despite many countries include supplementation during pregnancy in national policies. Common barriers limiting the effectiveness of these programmes, which would also apply to MNP supplementation programmes, include weak supply chains, low access to antenatal care (ANC) services, gastrointestinal side effects, and poor quality interactions between healthcare providers and women, low-quality behaviour change interventions to support and motivate women, and weak or non-existent monitoring systems used for programme improvement (Bhutta et al., 2009; Deitchler, Mathys, Mason, Winichagoon, & Tuazon, 2004; Galloway & Mcguire, 1994; Nguyen et al., 2008; Sununtnasuk, D 0 Agostino, & Fiedler, 2015; Tessama, Jefferds, Cogswell, & Carlton, 2009; WHO, 2012) . The causes of these barriers in a given country require careful review and appropriate resource allocation to be resolved. • At a minimum, most programmes should include indicators related to the monitoring of supply, coverage, and intake adherence. Policy indicators are also critical when shifting from an IFA to MMN supplementation programme.
• Development of a feasible and cost effective quality of services indicator is needed. Public health surveillance is the ongoing, systematic collection, analysis, interpretation, and dissemination of data for a health-related event that will be used in public health action to reduce morbidity and mortality and to improve health (CDC 2001; CDC 1999) . Nutrition surveillance is the ongoing, systematic collection, analysis, interpretation, and dissemination of data regarding nutritional status and nutrition programmes to make policy and programmatic decisions that will lead to improvements in the nutrition situation of a population. While national nutrition surveillance focuses on programmes in an individual country, global surveillance examines the types and number of nutrition programmes and key indicators, such as coverage in countries around the world.
Logic models are useful tools to structure and organize information, and they can be used to convey information and 
| Process for selecting indicators
Guided by these definitions of monitoring and surveillance, we reviewed practice-based evidence including monitoring manuals and 3 | RESULTS In 2014, in response to the DHS call for suggestions to modify their core questionnaire, the CDC, Strengthening Partnerships, Results, and Innovations in Nutrition Globally (SPRING), and MI suggested the following revisions to replace these two questions with a set of six questions. The questions would improve our understanding of where women obtain supplements, the formulation they take (e.g., iron, IFA, or MMN), whether the supplements were obtained free of charge or were paid for, and how many tablets were received during the preg- SPRING has developed a simple method to use DHS data to make a rapid, initial assessment of the distribution and consumption of IFA supplements among pregnant women (Sununtnasuk et al., 2015) .
| Summary of proposed indicators for MMN supplementation programmes
Briefly, this method assesses four sequential points at which an IFA supplementation programme commonly falters: ANC attendance/coverage, receipt of at least one IFA tablet, consumption of one or more IFA tablets, and the consumption of the ideal number of IFA tablets.
This information can be used to identify strong and weak components of a countries supplementation programme and inform areas where formative research or context assessments should be conducted to determine the causes of faltering performance and identify solutions. 
| Data collection systems/approaches
Monitoring and surveillance data primarily depend on routine healthcare systems (such as LMIS, HMIS, and ANC) and periodic sur- One major challenge to monitoring the key elements of ANC services is that systems are often established vertically and the individual components are the responsibility of different departments within the health sector (e.g., nutrition, family planning, malaria, and immunizations). This can result in fragmented programme monitoring systems that are inefficient, wasteful, and discouraging to frontline staff as they face an ever-increasing workload (Chaulagai et al., 2005) . Developing a streamlined monitoring system that makes better use of time and resources will require improved communication and coordination within the health sector. At the district level, one potential approach to promote intersectoral integration is to convene district health management meetings to coordinate ANC monitoring activities. For instance, the Indian Ministry of Health and Family
Welfare recently established "integrated monitoring teams" in highfocus districts to review action plans and discuss how to improve programme implementation and monitoring (Prasad, Chakraborty, Yadav, & Bhatia, 2013) .
There are also biological reasons for establishing integrated monitoring systems in settings with widespread infections. First, impaired micronutrient absorption and metabolic alterations occur during states of acute and chronic inflammation, especially in the case of iron, where reduced iron erythropoiesis is mediated by hepcidin (Allen, 2005) .
Second, safety concerns have been noted around providing iron in settings with recurrent infections, particularly malaria (WHO, 2007). The current evidence indicates that as long as women receive adequate healthcare, the benefits of supplementation during pregnancy likely outweigh the risks (Sangaré, van Eijk, Ter Kuile, Walson, & Stergachis, 2014) .
The WHO recommends daily IFA supplementation during pregnancy with the caveat that "in malaria-endemic areas, provision of iron and folic acid supplements should be implemented in conjunction with measures to prevent, diagnose and treat malaria" (WHO, 2016) . This recommendation may also be expected to apply to MMN supplementation; thus, integrating nutrition and malaria monitoring systems becomes advantageous. The World Malaria Report There are many gaps in current monitoring and surveillance systems, and more than one system will often need to be used to capture the necessary programme indicators. For example, the current HMIS cannot obtain information related to intake adherence because women are not taking the actual pills at the clinic and HMIS do not currently monitor whether women reported taking pills at a later ANC visit. In DHS surveys, women are asked about the number of pills consumed during their last pregnancy, which could be up to 5 years ago, 
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